Navis Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Navis Wealth Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$315K	Buy	2,463 +663	+37%	+$82.8K	0.16%	129
2025 Q4	$219K	Sell	1,800 -600	-25%	-$68.8K	0.09%	165
2025 Q3	$240K	Buy	+2,400	New	+$216K	0.18%	108
2025 Q1	–	Sell	-4,500	Closed	-$405K	–	110
2024 Q4	$405K	Buy	4,500 +2,100	+88%	+$203K	0.44%	53
2024 Q3	$237K	Sell	2,400 -280	-10%	-$27.5K	0.26%	89
2024 Q2	$248K	Hold	2,680	–	–	0.29%	84
2024 Q1	$254K	Buy	+2,680	New	+$249K	0.31%	80
2022 Q4	–	Sell	-6,612	Closed	-$524K	–	95
2022 Q3	$524K	Hold	6,612	–	–	0.81%	29
2022 Q2	$491K	Sell	6,612 -1,550	-19%	-$116K	0.53%	41
2022 Q1	$734K	Buy	8,162 +100	+1%	+$9.23K	0.65%	38
2021 Q4	$903K	Buy	8,062 +1,450	+22%	+$175K	0.76%	30
2021 Q3	$831K	Hold	6,612	–	–	0.58%	40
2021 Q2	$895K	Hold	6,612	–	–	0.75%	29
2021 Q1	$897K	Buy	6,612 +2	+0%	+$299	0.69%	32
2020 Q4	$931K	Buy	+6,610	New	+$847K	0.84%	27

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Navis Wealth Advisors's XBI Position: Q1 2026 in Review

Navis Wealth Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 37% in Q1 2026, buying an estimated $82.8K and bringing the position to 2,463 shares worth $315K. The position accounts for 0.16% of the portfolio, ranked #129.

Navis Wealth Advisors first reported a position in XBI in Q4 2020 and has held it in 15 quarters since. The position peaked at $931K in Q4 2020. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Navis Wealth Advisors held 2,463 shares of State Street SPDR S&P Biotech ETF worth $315K as of Q1 2026.
Navis Wealth Advisors bought 663 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $82.8K.
State Street SPDR S&P Biotech ETF made up 0.16% of Navis Wealth Advisors's portfolio in Q1 2026, its #129 holding.
Navis Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 15 quarters since.
Navis Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $931K in Q4 2020.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Navis Wealth Advisors's 13F filing for Q1 2026, filed 15 May 2026.